Leishmaniasis cutánea: experiencia en un hospital de referencia en Quito, Ecuador

Q4 Medicine Piel Pub Date : 2024-11-01 DOI:10.1016/j.piel.2024.04.003
Gabriela F. Cabezas-Herrera , Mónica P. Guevara-Novoa , Jesús Elías Dawaher-Dawaher , Jorge Luis Vélez-Páez
{"title":"Leishmaniasis cutánea: experiencia en un hospital de referencia en Quito, Ecuador","authors":"Gabriela F. Cabezas-Herrera ,&nbsp;Mónica P. Guevara-Novoa ,&nbsp;Jesús Elías Dawaher-Dawaher ,&nbsp;Jorge Luis Vélez-Páez","doi":"10.1016/j.piel.2024.04.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Leishmaniasis is a complex of tropical infectious diseases, which the incidence is increasing in Ecuador, the most frequent presentation in our country is the cutaneous form. The study aims to describe the clinical-epidemiological characteristics of cutaneous leishmaniasis in patients who attended our center.</div></div><div><h3>Methodology</h3><div>The recent study was observed in a second level hospital in the city of Quito, Ecuador, it included patients with a diagnosis of cutaneous leishmaniasis who were treated between October 1, 2015 and July 31, 2023.</div></div><div><h3>Results</h3><div>44 patients were studied with an average age of 33 years, with a predominance of males in 64%, 97% corresponded to new cases. Multiple lesions were presented in 52% of the cases and 48% had single lesions. The size of 2 to 3 cm predominated in 26% of the cases. 75% of the patients received treatment with intravenous meglumine antimoniate, 25% of the cases received intralesional treatment. After 90 days, 82% of the cases were cured, the remaining 18% required therapies based on oral antifungals.</div></div><div><h3>Conclusions</h3><div>In our reports, multiple injuries and in the exposed areas of the body were more frequent. We must consider oral antifungals and intralesional administration of meglumine antimoniate as effective alternatives in the treatment of cutaneous leishmaniasis.</div></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 9","pages":"Pages 531-535"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Piel","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213925124001977","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Leishmaniasis is a complex of tropical infectious diseases, which the incidence is increasing in Ecuador, the most frequent presentation in our country is the cutaneous form. The study aims to describe the clinical-epidemiological characteristics of cutaneous leishmaniasis in patients who attended our center.

Methodology

The recent study was observed in a second level hospital in the city of Quito, Ecuador, it included patients with a diagnosis of cutaneous leishmaniasis who were treated between October 1, 2015 and July 31, 2023.

Results

44 patients were studied with an average age of 33 years, with a predominance of males in 64%, 97% corresponded to new cases. Multiple lesions were presented in 52% of the cases and 48% had single lesions. The size of 2 to 3 cm predominated in 26% of the cases. 75% of the patients received treatment with intravenous meglumine antimoniate, 25% of the cases received intralesional treatment. After 90 days, 82% of the cases were cured, the remaining 18% required therapies based on oral antifungals.

Conclusions

In our reports, multiple injuries and in the exposed areas of the body were more frequent. We must consider oral antifungals and intralesional administration of meglumine antimoniate as effective alternatives in the treatment of cutaneous leishmaniasis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
皮肤利什曼病:厄瓜多尔基多一家转诊医院的经验
导言利什曼病是一种复杂的热带传染病,在厄瓜多尔的发病率不断上升,在我国最常见的表现形式是皮肤利什曼病。本研究旨在描述在本中心就诊的皮肤利什曼病患者的临床流行病学特征。研究方法近期的研究在厄瓜多尔基多市的一家二级医院进行,研究对象包括在2015年10月1日至2023年7月31日期间接受治疗的确诊为皮肤利什曼病的患者。研究结果44名患者的平均年龄为33岁,男性占64%,97%为新发病例。52%的病例出现多个病灶,48%为单个病灶。26%的病例以 2 至 3 厘米大小的病灶为主。75%的患者接受了静脉注射甲氧苄啶抗锑酸盐的治疗,25%的病例接受了腔内治疗。90天后,82%的病例治愈,其余18%的病例需要口服抗真菌药物治疗。我们必须考虑将口服抗真菌药和局部注射甲氧苄啶抗锑酸盐作为治疗皮肤利什曼病的有效替代方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Piel
Piel Medicine-Dermatology
CiteScore
0.10
自引率
0.00%
发文量
179
审稿时长
47 days
期刊介绍: La mejor revista para incrementar eficazmente sus habilidades diagnósticas y clínicas en dermatología, por la alta calidad de sus imágenes e iconografías, por el prestigio de sus colaboradores y por la actualidad de sus temas. Una publicación de máxima utilidad práctica para Especialistas y Profesionales de Atención Primaria.
期刊最新文献
Hidradenitis supurativa perianal o enfermedad de Crohn perianal: diagnóstico diferencial Abordaje de las úlceras orales recurrentes Bebé colodión: un reto terapéutico Novedades en la inmunoterapia de las enfermedades autoinmunes del tejido conectivo. Parte I: lupus eritematoso cutáneo Enfermedad vesículo-ampollar en una paciente con lupus eritematoso sistémico
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1